Press release
September 3, 2026
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Gyre Therapeutics, Inc. (GYRE)
SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre, Gyre Therapeutics or the Company) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with operations in the United States and China, today announced that Company management will participate in the